Brain implants fuel U.S.-China bioscience rivalry
Summary
Brain implants, known as brain-computer interfaces (BCIs), are devices that connect the brain to computers to help treat neurological problems. The U.S. is falling behind China in developing and approving these devices, which raises concerns about both healthcare and national security.Key Facts
- BCIs are being tested to help people recover functions lost due to conditions like stroke or spinal cord injury.
- China approved the world’s first commercial BCI this year that aids hand movement in spinal injury patients.
- The U.S. is experiencing delays in BCI development due to regulatory and funding issues.
- The National Security Commission on Emerging Biotechnology warns that China is advancing faster in this field.
- BCIs could impact military tech and improve artificial intelligence training.
- Companies such as Elon Musk’s Neuralink are leading U.S. efforts in BCI technology.
- U.S. experts suggest clearer government rules and payment plans are needed to speed up BCI approval and use.
- Privacy concerns exist over who controls brain data, and China currently has no specific laws protecting neural data.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
